Oral Bioavailability of Solid Formulation of GLPG1205 With and Without Food
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the amount of compound present in the blood (relative
bioavailability) after a single oral administration of GLPG1205 given as a capsule
formulation in fasted versus fed conditions in male healthy subjects.
Also, the safety and tolerability of a single oral dose of GLPG1205 given as a capsule
formulation under fasted and fed conditions will be assessed.